Homocysteine: Update on a new risk factor

  • Cleveland Clinic Journal of Medicine
  • November 1997,
  • 64
  • (10)
  • 543-549;

ABSTRACT

A high fasting plasma homocysteine level is an independent risk factor for atherosclerosis and venous thrombosis. Vitamin therapy can lower homocysteine levels, but no benefit has yet been demonstrated; studies using clinical outcomes as endpoints are now in progress.

View Abstract
Loading
  • Print
  • Download PDF
  • Article Alerts
  • Email Article
  • Citation Tools

Jump to section